Back to News
Market Impact: 0.6

APEI Earnings Rise 6%

APEINDAQ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsRegulation & LegislationM&A & RestructuringAnalyst EstimatesHealthcare & Biotech
APEI Earnings Rise 6%

American Public Education (APEI) delivered a strong Q2 2025, with GAAP revenue rising 6.5% to $162.8 million, beating consensus, and Adjusted EBITDA surging 38.2% to $15.1 million, surpassing internal guidance. Despite a GAAP diluted EPS miss attributed to a one-time $3.5 million preferred stock redemption loss, the quarter was marked by robust enrollment growth across all segments and the lifting of key regulatory restrictions on Rasmussen University. While the company faces ongoing cost pressures and the critical 90/10 federal funding ratio for APUS remains a compliance risk, management raised full-year 2025 Adjusted EBITDA guidance, signaling continued operational improvement.

Analysis

American Public Education (APEI) reported strong Q2 2025 operational results, characterized by a 6.5% year-over-year revenue increase to $162.8 million and a 38.2% surge in adjusted EBITDA to $15.1 million, surpassing both Wall Street estimates and internal guidance. The reported GAAP diluted loss per share of $0.02, which missed consensus, was directly attributable to a planned, one-time $3.5 million loss from the redemption of preferred stock. This strategic move is poised to generate long-term value by eliminating approximately $6 million in annual dividend payments beginning in 2026. Growth was underpinned by robust enrollment increases across all key segments, with net course registrations at APUS climbing 7.3%, Rasmussen University (RU) enrollment growing 7.4%, and Hondros College of Nursing (HCN) expanding by 13.5%. The positive operational momentum was further supported by the U.S. Department of Education lifting growth restrictions on RU and releasing a $24.5 million letter of credit, enhancing liquidity and expansion capabilities. Despite these strengths, a critical risk remains: the APUS 90/10 federal funding ratio stands at 89% for 2024, leaving a narrow margin for compliance. While the company raised its full-year 2025 adjusted EBITDA guidance to $81-$88 million, signaling confidence in its margin profile, investors must weigh this against the significant regulatory overhang.